Phase 3 Trial: Innovative Treatment Maintains Gastrointestinal Cancer Care Despite Low Platelet Challenges
Cancer therapy has long been hampered by the challenge of chemotherapy-induced thrombocytopenia (CIT), a condition characterized by dangerously low platelet ...
